These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3791781)

  • 21. Cardiac transplantation for doxorubicin cardiotoxicity.
    Grady KL; Jassak PF; Varricchio CG
    Prog Cardiovasc Nurs; 1987; 2(2):66-70. PubMed ID: 3295864
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary uptake in 67-gallium citrate scintigraphy-the 'negative heart' sign.
    Cooke SG; Davies ER; Goddard PR
    Postgrad Med J; 1989 Dec; 65(770):885-91. PubMed ID: 2616428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring cardiac function in patients receiving doxorubicin.
    Lu P
    Semin Nucl Med; 2005 Jul; 35(3):197-201. PubMed ID: 16098293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial assessment of doxorubicin cardiotoxicity in pediatric patients with quantitative radionuclide angiocardiography.
    Moodie DS; Dyment PG; Napoli C; Cook SA
    Cleve Clin Q; 1980; 47(4):327-31. PubMed ID: 7471466
    [No Abstract]   [Full Text] [Related]  

  • 25. Late, late doxorubicin cardiotoxicity.
    Gottlieb SL; Edmiston WA; Haywood LJ
    Chest; 1980 Dec; 78(6):880-2. PubMed ID: 7449470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adriamycin and the heart.
    Henderson IC; Frei TE
    N Engl J Med; 1979 Feb; 300(6):310-2. PubMed ID: 759884
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.
    Speyer JL; Green MD; Kramer E; Rey M; Sanger J; Ward C; Dubin N; Ferrans V; Stecy P; Zeleniuch-Jacquotte A
    N Engl J Med; 1988 Sep; 319(12):745-52. PubMed ID: 3137469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR2 and TLR3 expression as a biomarker for the risk of doxorubicin-induced heart failure.
    Liang S; Xinyong C; Hongmin Z; Jing W; Lang H; Ping Z
    Toxicol Lett; 2018 Oct; 295():205-211. PubMed ID: 29959987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocarditis associated with doxorubicin cardiotoxicity.
    Gaudin PB; Hruban RH; Beschorner WE; Kasper EK; Olson JL; Baughman KL; Hutchins GM
    Am J Clin Pathol; 1993 Aug; 100(2):158-63. PubMed ID: 8356947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases.
    Saini J; Rich MW; Lyss AP
    Ann Intern Med; 1987 Jun; 106(6):814-6. PubMed ID: 3579067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: role of radionuclide cardiac angiography.
    Agarwala S; Kumar R; Bhatnagar V; Bajpai M; Gupta DK; Mitra DK
    J Pediatr Surg; 2000 Dec; 35(12):1786-9. PubMed ID: 11101737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gallium-67 scintigraphic evaluation of primary dilated myocardiopathies in adults].
    Beuscart R; Foucher C; Asseman P; Leroy O; Duhamel A; Vergnes R; Lekieffre J
    Arch Mal Coeur Vaiss; 1987 Feb; 80(2):191-7. PubMed ID: 3107505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity.
    Valdés Olmos RA; ten Bokkel Huinink WW; Greve JC; Hoefnagel CA
    Clin Nucl Med; 1992 Mar; 17(3):163-7. PubMed ID: 1611784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ga-67 cardiac uptake.
    Lin DS; Tipton RE
    Clin Nucl Med; 1983 Dec; 8(12):603-4. PubMed ID: 6653015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
    Schwartz RG; McKenzie WB; Alexander J; Sager P; D'Souza A; Manatunga A; Schwartz PE; Berger HJ; Setaro J; Surkin L
    Am J Med; 1987 Jun; 82(6):1109-18. PubMed ID: 3605130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin (Adriamycin) cardiotoxicity.
    Weisburst MR; Pearlman ES; Capone RJ
    Conn Med; 1980 Mar; 44(3):133-6. PubMed ID: 7363615
    [No Abstract]   [Full Text] [Related]  

  • 39. Review of tests for monitoring doxorubicin-induced cardiomyopathy.
    Ganz WI; Sridhar KS; Ganz SS; Gonzalez R; Chakko S; Serafini A
    Oncology; 1996; 53(6):461-70. PubMed ID: 8960141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review.
    Freter CE; Lee TC; Billingham ME; Chak L; Bristow MR
    Am J Med; 1986 Mar; 80(3):483-5. PubMed ID: 3513562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.